Limitations of the Standard of Care for Patients with Brain Tumors

Dr. John de Groot, MD Anderson Cancer Center

“Since I started my training, there was the establishment of what’s currently the standard of care. Which is the concurrent use of radiation and temozolomide and adjuvant temozolomide. That, unfortunately, has not changed though, in the last 15 years. So although I got to see the transformation of the field and maybe for the first time, a large number of patients who have five years and beyond survival, we still have not been able to really make that a reality for a majority of patients. So we’ve unfortunately had some limitations in the advancements since that time.”

Along with Brains for the Cure, the Head for the Cure Foundation aims to change the future of treatment for brain tumor patients. Interested in learning more? Email [email protected].

Share this post

Share on facebook
Share on twitter
Share on pinterest
Share on email

Get the Latest from Brains for the Cure

Add your address to our mailing list to get monthly updates about progress in the fight against brain tumors, as well as new community opportunities.

Brains for the Cure is a program of the Head for the Cure Foundation, which is powered by the generous support of donors. Learn more about how you can join the fight.